References
- Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046–1060.
- Cid RJ, Merinopoulou E, Baggaley RF, et al. Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model. Pharmacoepidemiol Drug Saf. 2016;25:871–879.
- Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet. 2015;385:2197–2208.
- Bringhen S, Mateos MV, Zweegman S, et al. Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials. Haematologica. 2013;98:980–987.
- Gewirtz DA, Bristol ML, Yalowich JC. Toxicity issues in cancer drug development. Curr Opin Invest Drugs. 2010;11:612–614.
- Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–e548.
- Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med. 1977;63:200–207.
- Chylack LT, Jr, Wolfe JK, Singer DM, et al. The lens opacities classification system III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831–836.
- StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013.
- Klein R, Klein BEK. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest Ophthalmol Vis Sci. 2013;54:ORSF5–ORSF13.
- Hemminki K, Försti A, Tuuminen R, et al. The incidence of senile cataract and glaucoma is increased in patients with plasma cell dyscrasias: etiologic implications. Sci Rep. 2016;6:28500.
- Surguchev A, Surguchov A. Conformational diseases: looking into the eyes. Brain Res Bull. 2010;81:12–24.
- Klein BEK, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol. 1998;116:219–225.
- Jones R, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17:163–167.
- Broder MS, Sarsour K, Chang E, et al. Corticosteroid-related adverse events in patients with giant cell arteritis: a claims-based analysis. Semin Arthritis Rheum. 2016;46:246–252.
- Sinha A, Bagga A. Pulse steroid therapy. Indian J Pediatr. 2008;75:1057–1066.